» Articles » PMID: 21480968

The Association of Public Health Observatories (APHO) Diabetes Prevalence Model: Estimates of Total Diabetes Prevalence for England, 2010-2030

Overview
Journal Diabet Med
Specialty Endocrinology
Date 2011 Apr 13
PMID 21480968
Citations 52
Authors
Affiliations
Soon will be listed here.
Abstract

Aim: To provide robust estimates of the total prevalence of diabetes (including undiagnosed) in England to support effective planning and delivery of services.

Methods: Age- and sex-specific prevalence of diagnosed and undiagnosed diabetes in people aged 16 years and older [based on HbA(1c) of 6.5% (48 mmol/mol) or greater] were taken from the Health Survey for England 2006. Data from the Health Survey for England 2004 were used to adjust for ethnic difference in prevalence. A deprivation adjustment refined the geographical distribution of diabetes prevalence. Projected diabetes prevalence was calculated using trends in overweight and obesity prevalence from the Health Surveys for England 2003 to 2008.

Results: In 2010 there were an estimated 3.1 million (7.4%) people aged 16 years and older with diabetes in England. Comparisons between the 2008/2009 Quality and Outcomes Framework data and estimates for 2009 suggest that that 27.1% of the total number of people with diabetes are not included on general practice diabetes registers. The total number of adults with diabetes is projected to rise to 4.6 million or 9.5% by 2030. Approximately half of this increase is attributable to the changing age and ethnic group structure of the population and half is because of the rising prevalence of obesity.

Conclusions: This model estimates that the prevalence of total diabetes (diagnosed and undiagnosed) in England is higher than previously suggested. An ageing population and increasing prevalence of obesity imply that the prevalence of diabetes will continue to rise and health services should be planned accordingly.

Citing Articles

Estimating the burden of underdiagnosis within England: A modelling study of linked primary care data.

Anosova O, Head A, Collins B, Alexiou A, Darras K, Sutton M PLoS One. 2025; 20(1):e0313877.

PMID: 39813200 PMC: 11734898. DOI: 10.1371/journal.pone.0313877.


Mobile unidirectional airflow device reduces air contamination in an intravitreal outpatient clean room setting.

Fiore T, De Santi N, Pietrella D, Barcaccia M, Palmieri M, Lupidi M Int Ophthalmol. 2024; 45(1):8.

PMID: 39668307 DOI: 10.1007/s10792-024-03376-3.


Economic Assessment in Resource-Constrained Systems: Individual-Level Simulation Model in Wet Age-Related Macular Degeneration and Diabetic Macular Oedema.

Li T, Berdunov V, Hamilton R, Rojas Y, Buhrer C, Cox O Ophthalmol Ther. 2024; 13(10):2577-2597.

PMID: 39106031 PMC: 11408461. DOI: 10.1007/s40123-024-00999-8.


Healthcare Utilization and Its Correlates in Comorbid Type 2 Diabetes Mellitus and Generalized Anxiety Disorder.

Huang C, Lin C, Liu T, Lin P, Chu C, Wang J Psychiatr Q. 2024; 95(2):233-252.

PMID: 38639873 DOI: 10.1007/s11126-024-10072-z.


Bayesian networks and imaging-derived phenotypes highlight the role of fat deposition in COVID-19 hospitalisation risk.

Waddell T, Namburete A, Duckworth P, Eichert N, Thomaides-Brears H, Cuthbertson D Front Bioinform. 2023; 3:1163430.

PMID: 37293292 PMC: 10244647. DOI: 10.3389/fbinf.2023.1163430.